SFA
LEGN icon

Sequoia Financial Advisors’s Legend Biotech LEGN Stock Holding History

Sequoia Financial Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Sell
10,974
-7,708
-41% -$208K ﹤0.01% 1639
2026
Q1 		$338K Buy
+18,682
New +$356K ﹤0.01% 1496

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Sequoia Financial Advisors's LEGN Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Legend Biotech (LEGN) stake by 41% in Q2 2026, selling an estimated $208K and leaving 10,974 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Sequoia Financial Advisors first reported a position in LEGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $338K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Sequoia Financial Advisors held 10,974 shares of Legend Biotech worth $317K as of Q2 2026.
  • Sequoia Financial Advisors sold 7,708 Legend Biotech shares in Q2 2026, an estimated $208K.
  • Legend Biotech made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1639 holding.
  • Sequoia Financial Advisors first reported a position in Legend Biotech in Q1 2026 and has held it in 2 quarters since.
  • Sequoia Financial Advisors's Legend Biotech position peaked at $338K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.